EV/EBITDA
-8.43
+0.78+8.47%
Fri, 07 Feb 2025 22:50:50 GMT
Summary
- As of February 8, 2025, CLDX EV/EBITDA is -8.43, with a rise of +0.78 (+8.47%) during the most recent trading day.
- Over the past year, CLDX EV/EBITDA has increased by +5.78 (+40.68%).
- CLDX EV/EBITDA is now -110.59% below its all-time high of 79.64.
Performance
CLDX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CLDX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +8.5% | -8.4% | -8.3% |
| 1 m1 month | +19.8% | -19.7% | -19.4% |
| 3 m3 months | +16.3% | -16.3% | -15.9% |
| 6 m6 months | +36.5% | -32.1% | -31.9% |
| ytdytd | +12.2% | -12.1% | -11.9% |
| 1 y1 year | +40.7% | -26.9% | -38.1% |
| 5 y5 years | -1217.2% | +4461.6% | +863.2% |
CLDX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -10.51 | +19.8% | |
| 3 m | 3-month | -8.43 | at high | -10.92 | +22.8% |
| 6 m | 6-month | -8.43 | at high | -17.05 | +50.6% |
| 1 y | 1-year | -8.43 | at high | -23.40 | +64.0% |
| 3 y | 3-year | -7.96 | -5.9% | -24.67 | +65.8% |
| 5 y | 5-year | -0.20 | -4115.0% | -51.11 | +83.5% |
| alltime | all time | 79.64 | -110.6% | -1228 | +99.3% |
Celldex Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.43(-12.2%) |
| 2024 | -9.60(-38.9%) |
| 2023 | -15.71(-21.3%) |
| 2022 | -19.95(-25.5%) |
| 2021 | -26.78(+87.0%) |
| 2020 | -14.32(+2247.5%) |
| 2019 | -0.61(+281.3%) |
| 2018 | -0.16(-95.3%) |
| 2017 | -3.39(+13.8%) |
| 2016 | -2.98(-74.6%) |
| 2015 | -11.75(-13.0%) |
| 2014 | -13.50(-47.3%) |
| 2013 | -25.63(+233.3%) |
| 2012 | -7.69(+153.8%) |
| 2011 | -3.03(-111.6%) |
| 2010 | 26.07(-1048.0%) |
| 2009 | -2.75(+51.9%) |
| 2008 | -1.81(-21.0%) |
| Date | Value |
|---|---|
| 2007 | -2.29(-35.1%) |
| 2006 | -3.53(-50.0%) |
| 2005 | -7.06(-28.7%) |
| 2004 | -9.90(-36.0%) |
| 2003 | -15.48(+359.3%) |
| 2002 | -3.37(-63.0%) |
| 2001 | -9.10(-62.5%) |
| 2000 | -24.27(+132.0%) |
| 1999 | -10.46(+8.3%) |
| 1998 | -9.66(+18.2%) |
| 1997 | -8.17(+359.0%) |
| 1996 | -1.78(-60.4%) |
| 1995 | -4.50(+11.4%) |
| 1994 | -4.04(-67.8%) |
| 1993 | -12.55(-23.1%) |
| 1992 | -16.33(-26.0%) |
| 1991 | -22.06(+91.0%) |
| 1990 | -11.55 |
FAQ
- What is Celldex Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Celldex Therapeutics?
- What is CLDX EV/EBITDA year-to-date change?
- What is Celldex Therapeutics EV/EBITDA year-on-year change?
What is Celldex Therapeutics EV/EBITDA?
The current EV/EBITDA of CLDX is -8.43
What is the all time high EV/EBITDA for Celldex Therapeutics?
Celldex Therapeutics all-time high EV/EBITDA is 79.64
What is CLDX EV/EBITDA year-to-date change?
Celldex Therapeutics EV/EBITDA has changed by +1.17 (+12.19%) since the beginning of the year
What is Celldex Therapeutics EV/EBITDA year-on-year change?
Over the past year, CLDX EV/EBITDA has changed by +5.78 (+40.68%)